Zura Bio Ltd (ZURA)
2.80
-0.13
(-4.44%)
USD |
NASDAQ |
Nov 22, 12:06
Zura Bio Shareholders Equity (Quarterly): 153.05M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 153.05M |
| June 30, 2024 | 156.52M |
| March 31, 2024 | 61.01M |
| December 31, 2023 | 59.33M |
| September 30, 2023 | 63.21M |
| Date | Value |
|---|---|
| June 30, 2023 | 68.91M |
| March 31, 2023 | 27.86M |
| September 30, 2022 | -9.525M |
| June 30, 2022 | -8.435M |
| March 31, 2022 | -7.819M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.525M
Minimum
Sep 2022
156.52M
Maximum
Jun 2024
56.41M
Average
60.17M
Median
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Protalix BioTherapeutics Inc | 32.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 189.07M |
| Total Liabilities (Quarterly) | 18.24M |